Analytical characterization of coformulated antibodies as combination therapy

Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy

(2019) Mingyan Cao et al.   mAbs

Antibodies to watch in 2018

(2018) Hélène Kaplon et al.   mAbs

The benefits of immunotherapy combinations

(2017) Charles Schmidt   NATURE

Combination immunotherapy: a road map

(2017) Patrick A. Ott et al.   Journal for ImmunoTherapy of Cancer

Determination of critical quality attributes for monoclonal antibodies using quality by design principles

(2016) Nadja Alt et al.   BIOLOGICALS

Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept

(2016) Ick Hyun Cho et al.   mAbs

Technical Decision-Making with Higher Order Structure Data: Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It

(2015) Julie Y. Wei et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart

(2015) Svend Havelund et al.   PHARMACEUTICAL RESEARCH

Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications

(2014) Mark Haverick et al.   mAbs

A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies

(2013) Reza Esfandiary et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Recombinant antibody mixtures: Production strategies and cost considerations

(2012) Søren K. Rasmussen et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Compatibility and Stability of Pertuzumab and Trastuzumab Admixtures in i.v. Infusion Bags for Coadministration

(2012) Zephania W. Kwong Glover et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor

(2012) Klaus Koefoed et al.   mAbs

CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer

(2010) José Baselga et al.   Clinical Breast Cancer